- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
CVS Health Executive Vice President and CFO interviewed by Advisor Access
CVS Health (NYSE:CVS) Dave Denton, Executive Vice President and CFO of the company, was interviewed by Advisor Access on all aspects of the company and its focus.
CVS Health (NYSE:CVS) Dave Denton, Executive Vice President and CFO of the company, was interviewed by Advisor Access on all aspects of the company and its focus.
As quoted in the press release:
Advisor Access: CVS Health has been focused on the theme of driving more affordable, accessible, and effective care. Can you talk about how you are executing on each of those objectives?
Dave Denton: As the healthcare market continues to evolve, healthcare stakeholders are placing increased emphasis on making care more affordable, accessible, and effective. We believe no other company has the full suite of assets to deliver on each of these objectives. We’ve built the capabilities to integrate pharmacy care from the payer to the provider to the patient…
AA: Drug pricing has been in the news repeatedly over the last year. How is CVS approaching this issue?
DD: One of the biggest and most complex challenges facing the healthcare system is the increasing cost of medications. Price inflation on established branded products, as well as new specialty products coming to market at elevated price points, are creating new challenges for plan sponsors and patients alike…
Read the complete answers to these questions and the full interview with CVS, HERE.
About Advisor Access:
Advisor Access LLC brings compelling investment ideas to investors in the form of in-depth interviews with company management and the latest fact sheets and corporate presentations.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.